Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 108201-108250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT00583817
Endovascular Treatment of Thoracic Aortic Disease
NA
Enrolling by invitation
170 participants
Started: Oct 25, 2018 · Completed: Dec 31, 2027
9 conditions
2 sponsors
1 location
NCT03121469
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
NA
Active, not recruiting
47 participants
Started: Oct 25, 2018 · Completed: Jun 10, 2025
1 condition
1 sponsor
1 location
NCT03725761
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
PHASE2
Active, not recruiting
31 participants
Started: Oct 24, 2018 · Completed: Sep 30, 2027
1 condition
3 sponsors
3 locations
NCT03663218
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)
NA
Active, not recruiting
35 participants
Started: Oct 24, 2018 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT03613532
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
PHASE1
Active, not recruiting
102 participants
Started: Oct 24, 2018 · Completed: Feb 1, 2026
5 conditions
2 sponsors
1 location
NCT03426904
Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer
PHASE3
Active, not recruiting
708 participants
Started: Oct 24, 2018 · Completed: Dec 28, 2030
1 condition
1 sponsor
4 locations
NCT04173442
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
N/A
Recruiting
500 participants
Started: Oct 24, 2018 · Completed: Jan 30, 2026
2 conditions
2 sponsors
1 location
NCT03724136
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
NA
Enrolling by invitation
100 participants
Started: Oct 24, 2018 · Completed: Jul 31, 2025
18 conditions
1 sponsor
3 locations
NCT03654768
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
PHASE2
Active, not recruiting
84 participants
Started: Oct 24, 2018 · Completed: Jul 1, 2028
1 condition
2 sponsors
541 locations
NCT03588975
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
PHASE3
Recruiting
45 participants
Started: Oct 24, 2018 · Completed: Jun 30, 2027
4 conditions
1 sponsor
12 locations
NCT03536793
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
N/A
Recruiting
180 participants
Started: Oct 24, 2018 · Completed: Feb 28, 2029
2 conditions
2 sponsors
1 location
NCT03714490
MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer
PHASE2
Recruiting
200 participants
Started: Oct 23, 2018 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT03691714
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
36 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2024
4 conditions
2 sponsors
1 location
NCT03710109
Evaluation of an EEG Based Concussion System
N/A
Recruiting
150 participants
Started: Oct 23, 2018 · Completed: Dec 3, 2025
1 condition
1 sponsor
2 locations
NCT03196011
Traditional Versus Alternative Alignment in TKR
NA
Active, not recruiting
126 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03663504
Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery
PHASE4
Recruiting
630 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT03713983
Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder
N/A
Active, not recruiting
400 participants
Started: Oct 23, 2018 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT03665831
Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults
NA
Recruiting
28 participants
Started: Oct 23, 2018 · Completed: Sep 15, 2026
3 conditions
3 sponsors
1 location
NCT03721822
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
PHASE1
Recruiting
100 participants
Started: Oct 23, 2018 · Completed: Oct 23, 2026
3 conditions
1 sponsor
1 location
NCT03643133
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
PHASE2
Active, not recruiting
60 participants
Started: Oct 23, 2018 · Completed: Oct 31, 2033
1 condition
1 sponsor
31 locations
NCT03621696
"Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)"
PHASE2
Active, not recruiting
63 participants
Started: Oct 23, 2018 · Completed: Mar 10, 2026
1 condition
1 sponsor
1 location
NCT03746184
The Right Treatment for the Right Patient At the Right Time. a Study Following 5,000 Patients with Knee Osteoarthritis
N/A
Active, not recruiting
5,000 participants
Started: Oct 23, 2018 · Completed: Jul 31, 2025
1 condition
5 sponsors
1 location
NCT03674814
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
PHASE1
Active, not recruiting
35 participants
Started: Oct 23, 2018 · Completed: Mar 10, 2026
1 condition
3 sponsors
1 location
NCT03668340
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
PHASE2
Active, not recruiting
49 participants
Started: Oct 22, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03704662
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
NA
Recruiting
102 participants
Started: Oct 22, 2018 · Completed: Jun 1, 2031
1 condition
1 sponsor
1 location
NCT03737149
A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
NA
Active, not recruiting
10,500 participants
Started: Oct 22, 2018 · Completed: Jul 31, 2025
2 conditions
1 sponsor
30 locations
NCT03539822
Cabozantinib Plus Durvalumab with or Without Tremelimumab in Patients with Gastroesophageal Cancer and Other Gastrointestinal Malignancies
PHASE1/PHASE2
Recruiting
117 participants
Started: Oct 22, 2018 · Completed: Jan 31, 2028
4 conditions
3 sponsors
2 locations
NCT03018912
Validating the Use of a Subjectively Reported Sleep Vital Sign
NA
Active, not recruiting
1,000 participants
Started: Oct 22, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT03580785
Primary Failure of Eruption (PFE) : Highlighting of Clinical, Radiological and Genetic Diagnostic Criteria: Consequences on the Therapeutic Management
NA
Recruiting
50 participants
Started: Oct 22, 2018 · Completed: Oct 12, 2025
1 condition
1 sponsor
1 location
NCT03428828
Neurofeedback for Treatment Resistant Depression
NA
Recruiting
100 participants
Started: Oct 22, 2018 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT03539744
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
PHASE3
Active, not recruiting
265 participants
Started: Oct 22, 2018 · Completed: Nov 30, 2027
1 condition
2 sponsors
180 locations
NCT03180320
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
NA
Recruiting
150 participants
Started: Oct 22, 2018 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT03587064
Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
NA
Recruiting
640 participants
Started: Oct 22, 2018 · Completed: Apr 30, 2025
2 conditions
1 sponsor
24 locations
NCT03742297
Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
PHASE3
Active, not recruiting
462 participants
Started: Oct 22, 2018 · Completed: Jan 31, 2031
1 condition
1 sponsor
58 locations
NCT03717441
DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles
N/A
Recruiting
250 participants
Started: Oct 22, 2018 · Completed: Jun 15, 2026
1 condition
1 sponsor
1 location
NCT03619551
Conditioning SCID Infants Diagnosed Early
PHASE2
Recruiting
56 participants
Started: Oct 22, 2018 · Completed: Aug 1, 2030
1 condition
1 sponsor
52 locations
NCT03781648
Water Exchange With Narrow Band Imaging on Adenoma Detection
NA
Recruiting
360 participants
Started: Oct 20, 2018 · Completed: Oct 20, 2024
1 condition
1 sponsor
1 location
NCT03709719
Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia
PHASE2
Active, not recruiting
95 participants
Started: Oct 20, 2018 · Completed: Oct 30, 2028
1 condition
1 sponsor
1 location
NCT03641898
Intravascular Ultrasound-derived Assessment of Hemodynamically Negative Lesions in NSTEACS Patients
N/A
Recruiting
350 participants
Started: Oct 20, 2018 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03579394
Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
NA
Active, not recruiting
211 participants
Started: Oct 19, 2018 · Completed: Jul 31, 2028
3 conditions
1 sponsor
29 locations
NCT03674619
Cervical Radiculopathy Trial
NA
Active, not recruiting
180 participants
Started: Oct 19, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03474978
Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates
NA
Recruiting
320 participants
Started: Oct 19, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03520660
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
PHASE4
Active, not recruiting
121 participants
Started: Oct 19, 2018 · Completed: Dec 31, 2032
3 conditions
1 sponsor
1 location
NCT03729765
Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients
NA
Recruiting
60 participants
Started: Oct 19, 2018 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT03711539
Lifetime Endurance Exercise to Prevent Coronary Artery Disease
N/A
Recruiting
1,800 participants
Started: Oct 18, 2018 · Completed: Oct 1, 2025
3 conditions
3 sponsors
3 locations
NCT03732131
The Finnish Faecal Microbiota Transplantation Study (FINFMT)
N/A
Recruiting
200 participants
Started: Oct 18, 2018 · Completed: Jan 15, 2029
1 condition
19 sponsors
1 location
NCT03617731
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
PHASE3
Active, not recruiting
662 participants
Started: Oct 18, 2018 · Completed: Mar 31, 2027
1 condition
1 sponsor
72 locations
NCT04344496
East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction
N/A
Recruiting
2,000 participants
Started: Oct 18, 2018 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT03438552
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NA
Active, not recruiting
57 participants
Started: Oct 18, 2018 · Completed: Nov 30, 2030
1 condition
1 sponsor
12 locations
NCT03637543
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
PHASE2
Active, not recruiting
31 participants
Started: Oct 18, 2018 · Completed: Dec 31, 2026
1 condition
3 sponsors
5 locations
Previous
1
More pages
2162
2163
2164
2165
2166
2167
2168
More pages
2369
Next